Anders Ellern Bilgrau

570 total citations
20 papers, 272 citations indexed

About

Anders Ellern Bilgrau is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Anders Ellern Bilgrau has authored 20 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Anders Ellern Bilgrau's work include Gene expression and cancer classification (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Anders Ellern Bilgrau is often cited by papers focused on Gene expression and cancer classification (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Anders Ellern Bilgrau collaborates with scholars based in Denmark, United States and Germany. Anders Ellern Bilgrau's co-authors include Martin Bøgsted, Karen Dybkær, Hans Erik Johnsen, Alexander Schmitz, Steffen Falgreen, Julie Støve Bødker, Malene Krag Kjeldsen, Rasmus Waagepetersen, Poul Svante Eriksen and Egon Toft and has published in prestigious journals such as Blood, PLoS ONE and BMC Bioinformatics.

In The Last Decade

Anders Ellern Bilgrau

20 papers receiving 263 citations

Peers

Countries citing papers authored by Anders Ellern Bilgrau

Since Specialization

Citations

This map shows the geographic impact of Anders Ellern Bilgrau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Ellern Bilgrau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Ellern Bilgrau more than expected).

Fields of papers citing papers by Anders Ellern Bilgrau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Ellern Bilgrau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Ellern Bilgrau. The network helps show where Anders Ellern Bilgrau may publish in the future.

Co-authorship network of co-authors of Anders Ellern Bilgrau

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Ellern Bilgrau. A scholar is included among the top collaborators of Anders Ellern Bilgrau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Ellern Bilgrau. Anders Ellern Bilgrau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort 2024 ·RMD Open ·Mia Glerup, Christoph Kessel, Dirk Foell, Lillemor Berntson, Anders Fasth, Charlotte Myrup, Ellen Nordal, Veronika Rypdal, Marite Rygg, Ellen Dalen Arnstad, Suvi Peltoniemi, Kristiina Aalto, (unknown), (unknown), Anders Ellern Bilgrau, Troels Herlin	6
2	Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial) 2023 ·Trials ·(unknown), (unknown), (unknown), Jens Brøndum Frøkjær, Anders Ellern Bilgrau, Srdan Novovic, (unknown), Michael Bau Mortensen, (unknown), Amer Hadi, (unknown), Wiktor Rutkowski, Miroslav Vujasinović, Matthias Löhr, Asbjørn Mohr Drewes, Søren Schou Olesen	3
3	Incidence of Orofacial Manifestations of Juvenile Idiopathic Arthritis From Diagnosis to Adult Care Transition: A Population‐Based Cohort Study 2023 ·Arthritis & Rheumatology ·Mia Glerup, (unknown), Annelise Küseler, Anne Estmann Christensen, Carlalberta Verna, Anders Ellern Bilgrau, Sven Erik Nørholt, Troels Herlin, Thomas Klit Pedersen, Peter Stoustrup	8
4	Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis 2022 ·Pediatric Rheumatology ·(unknown), (unknown), Thomas Klit Pedersen, Anders Ellern Bilgrau, Paolo M. Cattaneo, Mia Glerup, Peter Stoustrup	5
5	rags2ridges: A One-Stop- ℓ2 -Shop for Graphical Modeling of High-Dimensional Precision Matrices 2022 ·Journal of Statistical Software ·Carel F.W. Peeters, Anders Ellern Bilgrau, Wessel N. van Wieringen	3
6	Targeted Fused Ridge Estimation of Inverse Covariance Matrices from Multiple High-Dimensional Data Classes 2020 ·Amsterdam UMC (VU Amsterdam) - Institutional Repository ·Anders Ellern Bilgrau, Carel F.W. Peeters, Poul Svante Eriksen, Martin Bøgsted, Wessel N. van Wieringen	12
7	Cumulative Incidence of Orofacial Manifestations in Early Juvenile Idiopathic Arthritis: A Regional, Three‐Year Cohort Study 2019 ·Arthritis Care & Research ·Peter Stoustrup, Mia Glerup, Anders Ellern Bilgrau, Annelise Küseler, Carlalberta Verna, Anne Estmann Christensen, Kasper Dahl Kristensen, Sven Erik Nørholt, Marinka Twilt, Troels Herlin, Thomas Klit Pedersen	27
8	High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma 2016 ·Experimental Hematology ·(unknown), (unknown), Maria Bach Laursen, Steffen Falgreen, Anders Ellern Bilgrau, Julie Støve Bødker, (unknown), (unknown), Alexander Schmitz, (unknown), Hans Erik Johnsen, Martin Bøgsted, Jacob Giehm Mikkelsen, Karen Dybkær	55
9	Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates 2016 ·BMC Bioinformatics ·Anders Ellern Bilgrau, Steffen Falgreen, (unknown), Malene Krag Kjeldsen, Julie Støve Bødker, Hans Erik Johnsen, Karen Dybkær, Martin Bøgsted	4
10	hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine 2016 ·PLoS ONE ·Steffen Falgreen, Anders Ellern Bilgrau, Rasmus Froberg Brøndum, Lasse Hjort Jakobsen, (unknown), (unknown), Tarec Christoffer El‐Galaly, Julie Støve Bødker, Alexander Schmitz, Ken H. Young, Hans Erik Johnsen, Karen Dybkær, Martin Bøgsted	6
11	GMCM: Unsupervised Clustering and Meta-Analysis Using Gaussian Mixture Copula Models 2016 ·Journal of Statistical Software ·Anders Ellern Bilgrau, Poul Svante Eriksen, Jakob Gulddahl Rasmussen, Hans Erik Johnsen, Karen Dybkær, (unknown)	16
12	Bone Marrow Aspiration: A Randomized Controlled Trial Assessing the Quality of Bone Marrow Specimens Using Slow and Rapid Aspiration Techniques and Evaluating Pain Intensity 2015 ·Acta Haematologica ·Mette Grønkjær, (unknown), (unknown), Preben Johansen, (unknown), Martin Bøgsted, Anders Ellern Bilgrau, Paw Jensen	14
13	A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait 2015 ·British Journal of Haematology ·Tarec Christoffer El‐Galaly, Anders Ellern Bilgrau, Peter de Nully Brown, Karen Juul Mylam, (unknown), Lars Møller Pedersen, Anne Ortved Gang, Hans Bentzen, Maja Bech Juul, Olav J. Bergmann, Robert Schou Pedersen, Berit Jamie Nielsen, Hans Erik Johnsen, Karen Dybkær, Martin Bøgsted, Martin Hutchings	25
14	Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man 2014 ·BMC Immunology ·(unknown), Mette Nyegaard, Martin Bøgsted, Alexander Schmitz, Julie Støve Bødker, (unknown), Martín Pérez‐Andrés, Steffen Falgreen, Anders Ellern Bilgrau, Malene Krag Kjeldsen, Michael Gaihede, Martin Agge Nørgaard, John Bæch, Marie-Louise M. Grønholdt, Frank Svendsen Jensen, Preben Johansen, Karen Dybkær, Hans Erik Johnsen	9
15	Stable phenotype of B-cell subsets following cryopreservation and thawing of normal human lymphocytes stored in a tissue biobank 2014 ·Cytometry Part B Clinical Cytometry ·(unknown), Anders Ellern Bilgrau, Alexander Schmitz, Steffen Falgreen, (unknown), (unknown), John Bæch, (unknown), Michael Gaihede, Malene Krag Kjeldsen, Julie Støve Bødker, Karen Dybkær, Martin Bøgsted, Hans Erik Johnsen	23
16	Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank 2014 ·Cytometry Part B Clinical Cytometry ·(unknown), Anders Ellern Bilgrau, Alexander Schmitz, Steffen Falgreen, (unknown), (unknown), John Bæch, (unknown), Michael Gaihede, Malene Krag Kjeldsen, Julie Støve Bødker, Karen Dybkær, Martin Bøgsted, Hans Erik Johnsen	19
17	A Multiple Myeloma Classification System That Associates Normal Bone Marrow B-Cell Subset Phenotypes with Disease Stage and Prognosis 2014 ·Blood ·Hans Erik Johnsen, Julie Støve Bødker, Alexander Schmitz, Malene Krag Kjeldsen, (unknown), Steffen Falgreen, Anders Ellern Bilgrau, Tarec Christoffer El‐Galaly, Karen Dybkær, Martin Bøgsted	2
18	Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma 2013 ·PLoS ONE ·Martin Bøgsted, Anders Ellern Bilgrau, Christopher P. Wardell, Uta Bertsch, Alexander Schmitz, Julie Støve Bødker, Malene Krag Kjeldsen, Hartmut Goldschmidt, Gareth J. Morgan, Karen Dybkær, Hans Erik Johnsen	9
19	Interrater Reliability of Diagnostic Methods in Traditional Indian Ayurvedic Medicine 2013 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Anders Ellern Bilgrau, Rasmus Waagepetersen, Egon Toft, Ramjee Prasad	25
20	A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells 2012 ·BMC Genomics ·(unknown), Anders Ellern Bilgrau, María Rodrigo-Domingo, (unknown), Alexander Schmitz, Mads Sønderkær, Julie Støve Bødker, Steffen Falgreen, Mette Nyegaard, Hans Erik Johnsen, Kåre Lehmann Nielsen, Karen Dybkær, Martin Bøgsted	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact